About heart disease. CDC. 2015. https://www.cdc.gov/heartdisease/about.htm.
Lee SH, et al. Prevalence of lipid abnormalities among treated patients with stable CHD: the dyslipidemia international study (DYSIS) II South Korea results. Atherosclerosis. 2015;241:e131–2.
Article
Google Scholar
Goldstein JL, et al. Hyperlipidemia in coronary heart-disease: I. Lipid-levels in 500 survivors of myocardial-infarction. J Clin Invest. 1973;52:1533–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lynch A, et al. The Bacteroidales produce an N-acylated derivative of glycine with both cholesterol-solubilising and hemolytic activity. Scientific Reports. 2017;7:13270.
Article
PubMed
PubMed Central
CAS
Google Scholar
Benjamin EJ, et al. Heart disease and stroke statistics-2017 update a report from the American Heart Association. Circulation. 2017;135:E146–603.
Article
PubMed
PubMed Central
Google Scholar
Rafieian-Kopaei M, Setorki M, Doudi M, Baradaran A, Nasri H. Atherosclerosis: process, indicators, risk factors and new hopes. Int J Prev Med. 2014;5:927–46.
PubMed
PubMed Central
Google Scholar
Mailer RKW, Gistera A, Polyzos KA, Ketelhuth DFJ, Hansson GK. Hypercholesterolemia induces differentiation of regulatory T cells in the liver. Circ Res. 2017;120:1740–53.
Article
CAS
PubMed
Google Scholar
Cassar A, Holmes DR, Rihal CS, Gersh BJ. Chronic coronary artery disease: diagnosis and management. Mayo Clinic Proc. 2009;84:1130–46.
Article
CAS
Google Scholar
Baila-Rueda L, et al. Cholesterol oversynthesis markers define familial combined hyperlipidemia versus other genetic hypercholesterolemias independently of body weight. J Nutr Biochem. 2018;53:48–57.
Article
CAS
PubMed
Google Scholar
Civeira F, International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004;173:55-68.
Article
CAS
PubMed
Google Scholar
Yamanashi Y, Takada T, Yoshikado T, Shoda J, Suzuki H. NPC2 regulates biliary cholesterol secretion via stimulation of ABCG5/G8-mediated cholesterol transport. Gastroenterology. 2011;140:1664–74.
Article
CAS
PubMed
Google Scholar
Voet D. Voet, JG. Wiley: 2010.
Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343:425–30.
Article
CAS
PubMed
Google Scholar
Cerqueira NM, et al. Cholesterol biosynthesis: a mechanistic overview. Biochemistry. 2016;55:5483–506.
Article
CAS
PubMed
Google Scholar
Kannel WB, Dawber TR, Friedman GD, Glennon WE, McNamara PM. Risk factors in coronary heart disease. An evaluation of several serum lipids as predictors of coronary heart disease; the Framingham study. Ann Intern Med. 1964;61:888.
Article
CAS
PubMed
Google Scholar
Rosenson RS, et al. Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges. Circulation. 2013;128:1256–67.
Article
PubMed
Google Scholar
Catapano AL, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37:2999–3058.
Article
PubMed
Google Scholar
Sorci-Thomas MG, Thomas MJ. Microdomains, inflammation, and atherosclerosis. Cir Res. 2016;118:679–91.
Article
CAS
Google Scholar
Morgan AE, Mooney KM, Wilkinson SJ, Pickles NA, Mc Auley MT. Cholesterol metabolism: a review of how ageing disrupts the biological mechanisms responsible for its regulation. Ageing Res Rev. 2016;27:108–24.
Article
CAS
PubMed
Google Scholar
Grundy SM. Does dietary cholesterol matter? Curr Atheroscler Rep. 2016;18:68.
Article
PubMed
CAS
Google Scholar
van der Velde AE, Brufau G, Groen AK. Transintestinal cholesterol efflux. Curr Opin Lipidol. 2010;21:167–71.
Article
PubMed
CAS
Google Scholar
Le May C, et al. Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1. Arterioscler Thromb Vasc Biol. 2013;33:1484–93.
Article
CAS
PubMed
Google Scholar
Yu L, et al. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion. Proc Natl Acad Sci U S A. 2002;99:16237–42.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gerard P, et al. Gnotobiotic rats harboring human intestinal microbiota as a model for studying cholesterol-to coprostanol conversion. FEMS Microbiol Ecol. 2004;47:337–43.
Article
CAS
PubMed
Google Scholar
Rosenfeld RS, Fukushima DK, Hellman L, Gallagher TF. The transformation of cholesterol to coprostanol. J Biol Chem. 1954;211:301–11.
CAS
PubMed
Google Scholar
Midtvedt AC, Midtvedt T. Conversion of cholesterol to coprostanol by the intestinal microflora during the 1st 2 years of human life. J Pediatr Gastroenterol Nutr. 1993;17:161–8.
Article
CAS
PubMed
Google Scholar
Matey-Hernandez ML, et al. Genetic and microbiome influence on lipid metabolism and dyslipidemia. Physiol Genomics. 2018;50:117–26.
Article
CAS
PubMed
Google Scholar
Nakaya K, Ikewaki K. Microbiota and HDL metabolism. Curr Opin Lipidol. 2018;29:18–23..
Article
CAS
PubMed
Google Scholar
Karlsson FH, et al. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun. 2012;3:1245.
Article
PubMed
CAS
Google Scholar
Yang T, et al. Gut dysbiosis is linked to hypertension. Hypertension. 2015;65:1331–40.
Article
CAS
PubMed
Google Scholar
Magrini V, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–131.
Article
PubMed
Google Scholar
Nakaya K, Ikewaki K. Microbiota and HDL metabolism. Microbiota and HDL metabolism. 2018;29:18–23.
CAS
Google Scholar
Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207–14.
Article
CAS
Google Scholar
Nicholson JK, et al. Host-gut microbiota metabolic interactions. Sci. 2012;336:1262–7.
Article
CAS
Google Scholar
Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr. 2002;22:283.
Article
CAS
PubMed
Google Scholar
Jia W, Li H, Zhao L, Nicholson JK. Gut microbiota: a potential new territory for drug targeting. Nat Rev Drug Discov. 2008;7:123–9.
Article
CAS
PubMed
Google Scholar
Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Sci. 2012;336:1268–73.
Article
CAS
Google Scholar
Quigley EMM. Gut bacteria in health and disease. Gastroenterol Hepatol. 2013;9:560.
Google Scholar
Mahmoodpoor F, Saadat YR, Barzegari A, Ardalan M, Vahed SZ. The impact of gut microbiota on kidney function and pathogenesis. Biomed Pharmacother. 2017;93:412–9.
Article
CAS
PubMed
Google Scholar
Tang WHW, Hazen SL. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest. 2014;124:4204–11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Allayee H, Hazen SL. Contribution of gut bacteria to lipid levels. Circ Res. 2015;117:750–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nutting CW, Islam S, Daugirdas JT. Vasorelaxant effects of short chain fatty acid salts in rat caudal artery. Am J Physiol. 1991;261:H561–7.
CAS
PubMed
Google Scholar
Sandek A, et al. Altered intestinal function in patients with chronic heart failure. J Am Coll Cardiol. 2007;50:1561–9.
Article
CAS
PubMed
Google Scholar
Sobko T, et al. Generation of NO by probiotic bacteria in the gastrointestinal tract. Free Radic Biol Med. 2006;41:985–91.
Article
CAS
PubMed
Google Scholar
Fernandez F, Hill MJ. Proceedings: the production of vitamin K by human intestinal bacteria. J Med Microbiol. 1975;8:pix.
de Andrade J, et al. The effect of thiamine deficiency on inflammation, oxidative stress and cellular migration in an experimental model of sepsis. J Inflamm (Lond). 2014;11:11.
Article
CAS
Google Scholar
Afsar B, Vaziri N, Aslan G, Tarim K, Kanbay M. Gut hormones and gut microbiota: implications for kidney function and hypertension. J Am Soc Hypertens. 2016;10:954–61.
Article
CAS
PubMed
Google Scholar
Lyte M. Probiotics function mechanistically as delivery vehicles for neuroactive compounds: microbial endocrinology in the design and use of probiotics. Bioessays. 2011;33:574–81.
Article
CAS
PubMed
Google Scholar
Gregory JC, et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem. 2015;290:5647–60.
Article
CAS
PubMed
Google Scholar
Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation. 1997;96:4095–103.
Article
CAS
PubMed
Google Scholar
Mitra S, et al. In silico analyses of metagenomes from human atherosclerotic plaque samples. Microbiome. 2015;3:38.
Article
PubMed
PubMed Central
Google Scholar
Chistiakov DA, Bobryshev YV, Kozarov E, Sobenin IA, Orekhov AN. Role of gut microbiota in the modulation of atherosclerosis-associated immune response. Front Microbiol. 2015;6:671.
Article
PubMed
PubMed Central
Google Scholar
Kim S, et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci (Lond). 2018;132:701–18.
Article
CAS
Google Scholar
Karbach SH, et al. Gut microbiota promote angiotensin II–Induced arterial hypertension and vascular dysfunction. J Am Heart Assoc. 2016;5:e003698.
Tang WH, Kitai T, Hazen SL. Gut microbiota in cardiovascular health and disease. Circ Res. 2017;120:1183–96.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yin J, et al. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. J Am Heart Assoc. 2015;4:e002699.
Fu J, et al. The gut microbiome contributes to a substantial proportion of the variation in blood lipids. Circ Res. 2015;117:817–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Taranto MP, Medici M, Perdigon G, Ruiz Holgado AP, Valdez GF. Evidence for hypocholesterolemic effect of lactobacillus reuteri in hypercholesterolemic mice. J Dairy Sci. 1998;81:2336–40.
Article
CAS
PubMed
Google Scholar
Backhed F, et al. The gut microbiota as an environmental factor that regulates fat storage. National Academy of Sciences of the United States of America. 2004;101:15718–23.
Article
CAS
Google Scholar
Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A. 2008;105:13580–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chiang JY. Bile acids: regulation of synthesis. J Lipid Res. 2009;50:1955–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ferrell JM, Boehme S, Li F, Chiang JY. Cholesterol 7alpha-hydroxylase-deficient mice are protected from high-fat/high-cholesterol diet-induced metabolic disorders. J Lipid Res. 2016;57:1144–54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li T, et al. Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity. J Biol Chem. 2012;287:1861–73.
Article
CAS
PubMed
Google Scholar
Broeders EPM, et al. The bile acid chenodeoxycholic acid increases human brown adipose tissue activity. Cell Metab. 2015;22:418–26.
Article
CAS
PubMed
Google Scholar
Kumar PS, Mason MR, Brooker MR, O'Brien K. Pyrosequencing reveals unique microbial signatures associated with healthy and failing dental implants. J Clin Periodontol. 2012;39:425–33.
Article
PubMed
PubMed Central
Google Scholar
Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev. 2009;89:147–91.
Article
CAS
PubMed
Google Scholar
de Aguiar Vallim TQ, Tarling EJ, Edwards PA. Pleiotropic roles of bile acids in metabolism. Cell Metab. 2013;17:657–69.
Article
PubMed
PubMed Central
CAS
Google Scholar
Song K-H, Li T, Owsley E, Strom S, Chiang JYL. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7α-hydroxylase gene expression. Hepatology. 2009;49:297–305.
Article
CAS
PubMed
Google Scholar
Stieger B. Recent insights into the function and regulation of the bile salt export pump (ABCB11). Curr Opin Lipidol. 2009;20:176–81.
Article
CAS
PubMed
Google Scholar
Mayerhofer CCK, et al. Increased secondary/primary bile acid ratio in chronic heart failure. J Card Fail. 2017;23:666–71.
Article
CAS
PubMed
Google Scholar
Dam H. The formation of coprosterol in the intestine: the action of intestinal bacteria on cholesterol. Biochem J. 1934;28:820–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lichtenstein AH. Intestinal cholesterol metabolism. Ann Med. 2009;22:49–52.
Article
Google Scholar
Illman RJ, Storer GB, Topping DL. White wheat flour lowers plasma cholesterol and increases cecal steroids relative to whole wheat flour, wheat bran and wheat pollard in rats. J Nutr. 1993;123:1094.
CAS
PubMed
Google Scholar
Benno P, et al. Examination of intestinal conversion of cholesterol to coprostanol in 633 healthy subjects reveals an age- and sex-dependent pattern. Microb Ecol Health Dis. 2005;17:200–4.
Article
CAS
Google Scholar
Midtvedt T, et al. Intestinal microbial conversion of cholesterol to coprostanol in man. Influence of antibiotics. APMIS. 1990;98(839).
Article
CAS
PubMed
Google Scholar
Veiga P, et al. Correlation between faecal microbial community structure and cholesterol-to-coprostanol conversion in the human gut. FEMS Microbiol Lett. 2005;242:81–6.
Article
CAS
PubMed
Google Scholar
Gerard P, et al. Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces. Appl Environ Microbiol. 2007;73:5742–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ren D, Li L, Schwabacher AW, Young JW, Beitz DC. Mechanism of cholesterol reduction to coprostanol by Eubacterium coprostanoligenes ATCC 51222. Steroids. 1996;61:33–40.
Article
CAS
PubMed
Google Scholar
Li L, Baumann CA, Meling DD, Sell JL, Beitz DC. Effect of orally administered Eubacterium coprostanoligenes ATCC 51222 on plasma cholesterol concentration in laying hens. Poultry Sci. 1996;75:743–5.
Article
CAS
Google Scholar
Antharam VC, et al. An integrated metabolomic and microbiome analysis identified specific gut microbiota associated with fecal cholesterol and coprostanol in clostridium difficile infection. PLoS One. 2016;11:e0148824.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lye HS, Rusul G, Liong MT. Removal of cholesterol by Lactobacilli via incorporation and conversion to coprostanol. J Dairy Sci. 2010;93:1383–92.
Article
CAS
PubMed
Google Scholar
Tahri K, Grill JP, Schneider F. Involvement of trihydroxyconjugated bile salts in cholesterol assimilation by bifidobacteria. Curr Microbiol. 1997;34:79–84.
Article
CAS
PubMed
Google Scholar
Gerard P. Metabolism of cholesterol and bile acids by the gut microbiota. Pathogens. 2013;3:14–24.
Article
PubMed
PubMed Central
CAS
Google Scholar
Macfarlane GT, Macfarlane S. Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol. 2011;S120-S127.
Article
CAS
PubMed
Google Scholar
Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med. 2011;62:361–80.
Article
CAS
PubMed
Google Scholar
Macfarlane S, Macfarlane GT. Regulation of short-chain fatty acid production. Proc Nutr Soc. 2003;62:67–72.
Article
CAS
PubMed
Google Scholar
David LA, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559–63.
Article
CAS
PubMed
Google Scholar
Krishnan S, Alden N, Lee K. Pathways and functions of gut microbiota metabolism impacting host physiology. Curr Opin Biotechnol. 2015;36:137–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
De Preter V, Coopmans T, Rutgeerts P, Verbeke K. Influence of long-term administration of lactulose and saccharomyces boulardii on the colonic generation of phenolic compounds in healthy human subjects. J Am Coll Nutr. 2006;25:541–9.
Article
PubMed
Google Scholar
Mell B, et al. Evidence for a link between gut microbiota and hypertension in the Dahl rat. Physiol Genomics. 2015;47:187–97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pluznick J. A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbiomes. 2014;5:202–7.
Article
Google Scholar
Koeth RA, et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nature Medicine. 2013;19:576–85.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Z, et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57–63.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zeisel SH, Warrier M. Trimethylamine N-oxide, the microbiome, and heart and kidney disease. Annu Rev Nutr. 2017;37:157–81.
Article
CAS
PubMed
Google Scholar
Falony G, Vieira-Silva S, Raes J. Microbiology meets big data: The case of gut microbiota-derived trimethylamine. Annu Rev Microbiol. 2015;69:305–21.
Article
CAS
PubMed
Google Scholar
Tang WHW, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368:575–1584.
Article
CAS
Google Scholar
Chittim CL, Martinez Del Campo A, Balskus EP. Gut bacterial phospholipase Ds support disease-associated metabolism by generating choline. Nature Microbiol. 2019;4:155–63.
Article
CAS
Google Scholar
Phillips IR, et al. The molecular biology of the flavin-containing monooxygenases of man. Chemico-Biological Interactions. 1995;96:17–32.
Article
CAS
PubMed
Google Scholar
Ghazalpour A, Cespedes I, Bennett BJ, Allayee H. Expanding role of gut microbiota in lipid metabolism. Curr Opin Lipidol. 2016;27:141–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Al-Obaide MAI, et al. Gut microbiota-dependent trimethylamine-N-oxide and serum biomarkers in patients with T2DM and advanced CKD. J Clin Med. 2017;6:86.
Article
PubMed Central
CAS
Google Scholar
Zhu W, et al. Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk. Cell. 2016;165:111–24.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022–3.
Article
CAS
PubMed
Google Scholar
Liu TX, Niu HT, Zhang SY. Intestinal microbiota metabolism and atherosclerosis. Chin Med J (Engl). 2015;128:2805–11.
Article
CAS
Google Scholar
Wang Z, et al. Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell. 2015;163:1585–95.
Article
CAS
PubMed
PubMed Central
Google Scholar
Martin FPJ, et al. Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol. 2008;4:157.
Article
PubMed
PubMed Central
CAS
Google Scholar
Libby P. Superficial erosion and the precision management of acute coronary syndromes: not one-size-fits-all. Eur Heart J. 2017;38:801–3.
PubMed
Google Scholar
Frostegård J. Immunity, atherosclerosis and cardiovascular disease. BMC Med. 2013;11:117.
Article
PubMed
PubMed Central
CAS
Google Scholar
Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011;12:204–12.
Article
CAS
PubMed
Google Scholar
Chmielewski P. Leukocyte count, systemic inflammation, and health status in older adults: a narrative review. Anthropol Rev. 2018;81:81–101.
Article
Google Scholar
Zheng Y, et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med. 2008;14:282–9.
Article
CAS
PubMed
Google Scholar
Sugimoto K, et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008;118:534–44.
CAS
PubMed
PubMed Central
Google Scholar
Wang X, et al. Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes. Nat. 2014;514:237–41.
Article
CAS
Google Scholar
Korporaal SJ, et al. Platelet activation by oxidized low density lipoprotein is mediated by CD36 and scavenger receptor-A. Arterioscler Thromb Vasc Biol. 2007;27:2476–83.
Article
CAS
PubMed
Google Scholar
Kaptoge S, et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. EurHeart J. 2014;35:578–89.
CAS
Google Scholar
Tanti JF, et al. Alteration in insulin action: role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling. Annales d'Endocrinologie. 2004;65:43–8.
Article
CAS
PubMed
Google Scholar
Baidya SG, Zeng QT. Helper T cells and atherosclerosis: the cytokine web. Postgrad Med J. 2005;81:746–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
Menni C, et al. Gut microbial diversity is associated with lower arterial stiffness in women. Eur Heart J. 2018;39:2390–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Le Chatelier E, et al. Richness of human gut microbiome correlates with metabolic markers. Nat. 2013;500:541–6.
Article
CAS
Google Scholar
Mikelsaar M, et al. Intestinal Lactobacillus sp. is associated with some cellular and metabolic characteristics of blood in elderly people. Anaerobe. 2010;16:240–6.
Article
CAS
PubMed
Google Scholar
van den Munckhof ICL, et al. Role of gut microbiota in chronic low-grade inflammation as potential driver for atherosclerotic cardiovascular disease: a systematic review of human studies. Obesity Reviews. 2018;19:1719–34.
Article
PubMed
Google Scholar
Claesson MJ, et al. Gut microbiota composition correlates with diet and health in the elderly. Nat. 2012;488:178–84.
Article
CAS
Google Scholar
Martinez I, et al. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J. 2013;7:269–80.
Article
CAS
PubMed
Google Scholar
O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Reports. 2006;7:688–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Canny GO, McCormick BA. Bacteria in the intestine, helpful residents or enemies from within? Infect Immun. 2008;76:3360–73.
Article
CAS
PubMed
PubMed Central
Google Scholar
Halabi-Tawil M, et al. Cutaneous manifestations of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Br J Dermatol. 2009;160:645–51.
Article
CAS
PubMed
Google Scholar
Wright GP, Ehrenstein MR, Stauss HJ. Regulatory T-cell adoptive immunotherapy: potential for treatment of autoimmunity. Expert Rev Clin Immunol. 2011;7:213.
Article
CAS
PubMed
Google Scholar
Saurer L, Mueller C. T cell-mediated immunoregulation in the gastrointestinal tract. Allergy. 2009;64:505–19.
Article
CAS
PubMed
Google Scholar
Katoh H, Zheng P, Liu Y. FOXP3: genetic and epigenetic implications for autoimmunity. J Autoimmun. 2013;41:72–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gil-Cruz C, et al. Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy. Sci. 2019;366:881–6.
Article
CAS
Google Scholar
Atarashi K, et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nat. 2013;500:232–6.
Article
CAS
Google Scholar
Myles IA. Fast food fever: Reviewing the impacts of the western diet on immunity. Nutr J. 2014;13:61.
Article
PubMed
PubMed Central
CAS
Google Scholar
Sandek A, et al. Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure. Int J Cardiol. 2012;157:80–5.
Article
PubMed
Google Scholar
Maslowski K, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nat. 2009;461:1282–6.
Article
CAS
Google Scholar
Pluznick JL, et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci. 2013;110:4410–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Arpaia N, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nat. 2013;504:451–5.
Article
CAS
Google Scholar
Tolhurst G, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61:364–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Normén L, Laerke HN, Jensen BB, Langkilde AM, Andersson H. Small-bowel absorption of D-tagatose and related effects on carbohydrate digestibility: an ileostomy study. Am J Clin Nutr. 2001;73:105–10.
Article
PubMed
Google Scholar
Sun X, et al. Trimethylamine N-oxide induces inflammation and endothelial dysfunction in human umbilical vein endothelial cells via activating ROS-TXNIP-NLRP3 inflammasome. Biochem Biophys Res Commun. 2016;481:63–70.
Article
CAS
PubMed
Google Scholar
Rohrmann S, Linseisen J, Allenspach M, von Eckardstein A, Müller D. Plasma concentrations of trimethylamine-N-oxide are directly associated with dairy food consumption and low-grade inflammation in a German adult population. Br J Nutr. 2016;146:283–9.
Article
CAS
Google Scholar
Garber K. Drugging the gut microbiome. Nat Biotechnol. 2015;33:228–31.
Article
CAS
PubMed
Google Scholar
Ma G, et al. Trimethylamine N-oxide in atherogenesis: impairing endothelial self-repair capacity and enhancing monocyte adhesion. Biosci Rep. 2017;37:BSR20160244.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang YD, Chen WD, Yu D, Forman BM, Huang W. The G-Protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-κB) in mice. Hepatol. 2011;54:1421–32.
Article
CAS
Google Scholar
Pols TWH, et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metab. 2011;14:747–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Von Der Thüsen JH, et al. Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J. 2001;15:2730–2.
Article
CAS
Google Scholar
Rubic T, Lorenz RL. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Cardiovasc Res. 2006;69:527–35.
Article
CAS
PubMed
Google Scholar
Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int. 2006;26:1175–86.
Article
CAS
PubMed
Google Scholar
Krznarić Ž, Vranešić Bender D, Meštrović T. The mediterranean diet and its association with selected gut bacteria. Current Opin Clin Nutr Metab Care. 2019;22:401–6.
Article
Google Scholar
Widmer RJ, Flammer AJ, Lerman LO, Lerman A. The mediterranean diet, its components, and cardiovascular disease. Am J Med. 2015;128:229–38.
Article
PubMed
Google Scholar
Garcia-Mantrana I, Selma-Royo M, Alcantara C, Collado MC. Shifts on gut microbiota associated to mediterranean diet adherence and specific dietary intakes on general adult population. Front Microbiol. 2018;9:890.
Article
PubMed
PubMed Central
Google Scholar
Wilck N, et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nat. 2017;551:585–9.
Article
CAS
Google Scholar
Berger S, Raman G, Vishwanathan R, Jacques PF, Johnson EJ. Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr. 2015;102:276–94.
Article
CAS
PubMed
Google Scholar
Qin J, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nat. 2012;490:55–60.
Article
CAS
Google Scholar
Devkota S, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nat. 2012;487:104–8.
Article
CAS
Google Scholar
Kim KA, Gu W, Lee IA, Joh EH, Kim DH. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PLoS One. 2012;7:e47713.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yoshimoto S, et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nat. 2013;499:97–101.
Article
CAS
Google Scholar
Cani PD, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761–72.
Article
CAS
PubMed
Google Scholar
Everard A, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. 2013;110:9066–71.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ilan Y, et al. Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci U S A. 2010;107:9765–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Feuerer M, et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med. 2009;15:930–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Amar J, et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med. 2011;3:559–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sato J, et al. Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study. Scientific Reports. 2017;7:12115–0.
Article
PubMed
PubMed Central
CAS
Google Scholar
Filippo CD, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010;107:14691–3.
Article
PubMed
PubMed Central
Google Scholar
Fernandez ML. Rethinking dietary cholesterol. Current Opinion in Clinical Nutrition and Metabolic Care. 2012;15:117–21.
Article
CAS
PubMed
Google Scholar
Altmann SW, et al. Niemann-pick C1 like 1 protein is critical for intestinal cholesterol absorption. Sci. 2004;303:1201–4.
Article
CAS
Google Scholar
Lammert F, Wang DQ. New insights into the genetic regulation of intestinal cholesterol absorption. Gastroenterol. 2005;129:718–34.
Article
Google Scholar
Calder PC. Fatty acids and immune function: relevance to inflammatory bowel diseases. Int Rev Immunol. 2009;28:506–34.
Article
CAS
PubMed
Google Scholar
Calder PC. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. BBA - Molecular and Cell Biology Lipids. 2015;1851:469–84.
Article
CAS
Google Scholar
Shondelmyer K, Knight R, Sanivarapu A, Ogino S, Vanamala KPV. Ancient Thali diet: gut microbiota, immunity, and health. Yale J Biol Med. 2018;91:177–84.
CAS
PubMed
PubMed Central
Google Scholar
Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nature Reviews Gastroenterology & Hepatology. 2010;7:503–14.
Article
Google Scholar
Kekkonen RA, et al. Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol. 2008;14:2029–36.
Article
PubMed
PubMed Central
Google Scholar
Yadav H, Lee JH, Lloyd J, Walter P, Rane SG. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem. 2013;288:25088–97.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pereira DI, Gibson GR. Effects of consumption of probiotics and prebiotics on serum lipid levels in humans. Crit Rev Biochem Mol Biol. 2002;37:259–81.
Article
CAS
PubMed
Google Scholar
Harvey RE, Coffman KE, Miller VM. Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease. Women’s Health. 2015;11:239–57.
CAS
PubMed
Google Scholar
den Ruijter HM, Haitjema S, Asselbergs FW, Pasterkamp G. Sex matters to the heart: a special issue dedicated to the impact of sex related differences of cardiovascular diseases. Atherosclerosis. 2015;241:205–7.
Article
CAS
Google Scholar
Regitz-Zagrosek V, Kararigas G. Mechanistic pathways of wex differences in cardiovascular disease. Physiol Rev. 2017;97:1–37.
Article
PubMed
Google Scholar
Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism. Mol Metab. 2018;15:45–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang XW, Magkos F, Mittendorfer B. Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. J Clin Endocrinol Metab. 2011;96:885–93.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim ES, Menon V. Status of women in cardiovascular clinical trials. Arteriosclerosis Thrombosis and Vascular Biology. 2009;29:279–83.
Article
CAS
PubMed
Google Scholar
George J, et al. How does cardiovascular disease first present in women and men? Incidence of 12 cardiovascular diseases in a contemporary cohort of 1,937,360 people. Circ. 2015;132:1320–8.
Article
Google Scholar
Baker L, et al. The role of estrogen in cardiovascular disease. J Surg Res. 2003;115:25–44.
Article
CAS
Google Scholar
Chen J, et al. Impact of demographics on human gut microbial diversity in a US Midwest population. PeerJ. 2016;4:e1514.
Article
PubMed
PubMed Central
CAS
Google Scholar
Takagi T, et al. Differences in gut microbiota associated with age, sex, and stool consistency in healthy Japanese subjects. J Gastroenterol. 2019;54:53–63.
Article
PubMed
Google Scholar
Brooks AW, Priya S, Blekhman R, Bordenstein SR. Gut microbiota diversity across ethnicities in the United States. PLoS Biology. 2018;16:e2006842.
Article
PubMed
PubMed Central
CAS
Google Scholar
Chaturvedi N. Ethnic differences in cardiovascular disease. Heart (British Cardiac Society). 2003;89(681).
Article
PubMed
PubMed Central
Google Scholar
Gill PS, et al. Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening study (E-ECHOES). PLoS One. 2011;6:e26710.
Article
CAS
PubMed
PubMed Central
Google Scholar
Luhar, M. New report details high heart disease risk in South Asians in U.S. NBC News https://www.nbcnews.com/news/asian-america/new-report-details-high-heart-disease-risk-south-asians-u-n886991 (2018).
Guy-Walls P, Long JG. African Americans and heart disease. Health and Social Work. 2017;42:247–9.
Article
PubMed
Google Scholar
Barfield WL, Boyce CA. Sex, ethnicity, and CVD among women of African descent: an approach for the new era of genomic research. Global Heart. 2017;12:69–71.
Article
PubMed
Google Scholar
Biswas I, et al. Deep sequencing identifies ethnicity-specific bacterial signatures in the oral microbiome. PLoS ONE. 2013;8:e77287.
Article
CAS
Google Scholar
Fettweis JM, et al. Differences in vaginal microbiome in African American women versus women of European ancestry. Microbiol. 2014;160:2272–82.
Article
CAS
Google Scholar
Rothschild D, et al. Environment dominates over host genetics in shaping human gut microbiota. Nat. 2018;555:210.
Article
CAS
Google Scholar
Yatsunenko T, et al. Human gut microbiome viewed across age and geography. Nat. 2012;486:222–7.
Article
CAS
Google Scholar
Deschasaux M, et al. Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography. Nat Med. 2018;24:1526–31.
Article
CAS
PubMed
Google Scholar
Mc Auley MT, Mooney KM. Lipid metabolism and hormonal interactions: impact on cardiovascular disease and healthy aging. Expert Review of Endocrinology & Metabolism. 2014;9:357–67.
Article
CAS
Google Scholar
Childs BG, Li H, van Deursen JM. Senescent cells: a therapeutic target for cardiovascular disease. J Clin Invest. 2018;128:1217–28.
Article
PubMed
PubMed Central
Google Scholar
Costa, E., Santos-Silva, A., Paul, C. & González Gallego, J. Aging and cardiovascular risk. BioMed Research International e-pub ahead of print;10.1155/2015/871656871656-871652 (2015).
Groen A, Oude Elferink RP, Verkade HJ, Kuipers F. The ins and outs of reverse cholesterol transport. Ann Med. 2009;36:135–45.
Article
CAS
Google Scholar
Duan LP, Wang HH, Ohashi A, Wang DQ. Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: gender and age effects. Am J Physiol Gastrointest Liver Physiol. 2006;290:G269–76.
Article
CAS
PubMed
Google Scholar
Bertolotti M, et al. Age-related changes in bile acid synthesis and hepatic nuclear receptor expression. Eur J Clin Invest. 2007;37:501–8.
Article
CAS
PubMed
Google Scholar
van Tongeren SP, Slaets JP, Harmsen HJ, Welling GW. Fecal microbiota composition and frailty. Appl Environ Microbiol. 2005;71:6438–42.
Article
PubMed
PubMed Central
CAS
Google Scholar
Odamaki T, et al. Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study. BMC Microbiol. 2016;16:90.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kim S, Jazwinski SM. The gut microbiota and healthy aging: a mini-review. i. 2018;64:513–20.
CAS
Google Scholar
Rampelli S, et al. Functional metagenomic profiling of intestinal microbiome in extreme ageing. Aging-US. 2013;5:902–12.
Article
CAS
Google Scholar
Surana N, Kasper D. Deciphering the tete-a-tete between the microbiota and the immune system. J Clin Invest. 2014;124:4197–203.
CAS
PubMed
PubMed Central
Google Scholar
Sampson T, Mazmanian S. Control of brain development, function, and behavior by the microbiome. Cell Host & Microbe. 2015;17:565–76.
Article
CAS
Google Scholar
Clarke G, et al. Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014;28:1221–38.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kuntz TM, Gilbert JA. Introducing the microbiome into precision medicine. Trends Pharmacol Sci. 2017;38:81–91.
Article
CAS
PubMed
Google Scholar
Mahdy Ali K, Wonnerth A, Huber K, Wojta J. Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities. Br J Pharmacol. 2012;167:1177–94.
Article
CAS
PubMed
Google Scholar
Endo A. The discovery and development of HMG-CoA reductase inhibitors. J Lipid Res. 1992;33:1569.
CAS
PubMed
Google Scholar
The Lipid Study Group. Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. Lancet. 2002;359:1379–87.
Heart Protection Study Collaborative Group. MRC/BHF heart protection study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23–33.
Repa JJ, Dietschy JM, Turley SD. Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte. J Lipid Res. 2002;43:1864–74.
Article
CAS
PubMed
Google Scholar
Sudhop T, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circ. 2002;106:1943–8.
Article
CAS
Google Scholar
Schuster H. Improving lipid management – to titrate, combine or switch. Int J Clin Pract. 2004;58:689–94.
Article
CAS
PubMed
Google Scholar
Thompson PD, Panza G, Zaleski A, Taylor B. Statin-associated side effects. J Am Coll Cardiol. 2016;67:2395–410.
Article
CAS
PubMed
Google Scholar
Chowdhury R, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34:2940–8.
Article
CAS
PubMed
Google Scholar
Jakulj L, et al. Transintestinal cholesterol transport is active in mice and humans and controls ezetimibe-induced fecal neutral sterol excretion. Cell Metabolism. 2016;24:783–94.
Article
CAS
PubMed
Google Scholar
Wang HH, Portincasa P, Mendez-Sanchez N, Uribe M, Wang DQ. Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology. 2008;134:2101–210.
Article
CAS
PubMed
Google Scholar
Tuteja S, Ferguson JF. The gut microbiome and response to cardiovascular drugs. Circulation: Genomic and Precision Medicine. 2019;12:421–9.
CAS
Google Scholar
Clayton TA, et al. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci U S A. 2009;106:14728–33.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pelaz B, et al. Diverse applications of nanomedicine. ACS nano. 2017;11:2313–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim BY, Rutka JT, Chan WC. Nanomedicine. N Engl j med. 2010;363:2434–43.
Article
CAS
PubMed
Google Scholar
Mahmoudi M, et al. Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine. Chemical reviews. 2011;111:253–80.
Article
CAS
PubMed
Google Scholar
Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nature reviews Drug discovery. 2014;13:655–72.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zanganeh S, et al. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy. Immunotherapy. 2017;9:819–35.
Article
CAS
PubMed
Google Scholar
Mahmoudi M. Debugging Nano–Bio interfaces: systematic strategies to accelerate clinical translation of nanotechnologies. Trends Biotechnol. 2018;36:755–69.
Article
CAS
PubMed
Google Scholar
Muthu MS, Leong DT, Mei L, Feng SS. Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics. Theranostics. 2014;4:660–77.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bertrand N, et al. Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics. Nat Comm. 2017;8:777.
Article
CAS
Google Scholar
Monopoli MP, Åberg C, Salvati A, Dawson KA. Biomolecular coronas provide the biological identity of nanosized materials. Nature nanotechnol. 2012;7:779.
Article
CAS
Google Scholar
Mahmoudi M, et al. Protein− nanoparticle interactions: opportunities and challenges. Chemical reviews. 2011;111:5610–37.
Article
CAS
PubMed
Google Scholar
Hajipour MJ, Laurent S, Aghaie A, Rezaee F, Mahmoudi M. Personalized protein coronas: a “key” factor at the nanobiointerface. Biomaterials Science. 2014;2:1210–21.
Article
CAS
PubMed
Google Scholar
Hajipour MJ, et al. Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide. Nanoscale. 2015;7:8978–94.
Article
CAS
PubMed
Google Scholar
Caracciolo G, Caputo D, Pozzi D, Colapicchioni V, Coppola R. Size and charge of nanoparticles following incubation with human plasma of healthy and pancreatic cancer patients. Colloids and Surfaces B: Biointerfaces. 2014;123:673–8.
Article
CAS
PubMed
Google Scholar
Colapicchioni V, et al. Personalized liposome–protein corona in the blood of breast, gastric and pancreatic cancer patients. Int J Biochem Cell Biol. 2016;75:180–7.
Article
CAS
PubMed
Google Scholar
Papi M, Caracciolo G. Principal component analysis of personalized biomolecular corona data for early disease detection. Nano Today e-pub ahead of print. 2018.
Hadjidemetriou M, Al-Ahmady Z, Buggio M, Swift J, Kostarelos K. A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona. Biomaterials e-pub ahead of print. 2018.
Caracciolo G, et al. Disease-specific protein corona sensor arrays may have disease detection capacity. Nanoscale Horizons. 2019;4:1063–76.
Article
CAS
Google Scholar
Ashkarran AA, Suslick KS, Mahmoudi M. Magnetically levitated plasma proteins. Analytical Chemistry e-pub ahead of print (in press).
Ashkarran AA, et al. Evolving magnetically levitated plasma proteins detects opioid use disorder as a model disease. Advanced Healthcare Materials. 2020;9:e1901608.
Article
CAS
Google Scholar
Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019;25:44–56.
Article
CAS
PubMed
Google Scholar
Binsalamah ZM, Paul A, Prakash S, Shum-Tim D. Nanomedicine in cardiovascular therapy: recent advancements. Expert Rev Cardiovasc Ther. 2012;10:805–15.
Article
CAS
PubMed
Google Scholar
Lewis DR, Kamisoglu K, York AW, Moghe PV. Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis. Interdiscip Rev Nanomed Nanobiotechnol. 2011;3:400–20.
Article
CAS
Google Scholar
Laroui H, Sitaraman SV, Merlin D. Gastrointestinal delivery of anti-inflammatory nanoparticles. Methods Enzymol. 2012;509:101–25.
Article
CAS
PubMed
Google Scholar
Li AV, et al. Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination. Sci Transl Med. 2013;5(204):204ra130.
Article
PubMed
PubMed Central
CAS
Google Scholar
Li J, et al. Recyclable heparin and chitosan conjugated magnetic nanocomposites for selective removal of low-density lipoprotein from plasma. J Mater Sci Mater Med. 2014;25:1055–64.
Article
CAS
PubMed
Google Scholar
Gan J, et al. Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors. Biomaterials. 2018;178:95–108.
Article
CAS
PubMed
Google Scholar
Tu J, Xu Y, Xu J, Ling Y, Cai Y. Chitosan nanoparticles reduce LPS-induced inflammatory reaction via inhibition of NF-kappaB pathway in Caco-2 cells. Int J Biol Macromol. 2016;86:848–56.
Article
CAS
PubMed
Google Scholar
Wang Y, et al. Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity. ACS Nano. 2018;12:8943–60.
Article
CAS
PubMed
Google Scholar
Yang H, et al. Endosomal pH modulation by peptide-gold nanoparticle hybrids enables potent anti-inflammatory activity in phagocytic immune cells. Biomaterials. 2016;111:90–102.
Article
CAS
PubMed
Google Scholar
Mahmoudi M, et al. Multiscale technologies for treatment of ischemic cardiomyopathy. Nat Nanotechnol. 2017;12:845–55.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mahmoudi M, Pakpour S, Perry G. Drug-abuse nanotechnology: opportunities and challenges. ACS Chem Neurosci. 2018;9:2288–98.
Article
CAS
PubMed
Google Scholar
Mirshafiee V, Mahmoudi M, Lou K, Cheng J, Kraft M. Protein corona significantly reduces active targeting yield. Chem Commun. 2013;49:2557–9.
Article
CAS
Google Scholar
Behzadi S, et al. Protein corona change the drug release profile of nanocarriers: the “overlooked” factor at the nanobio interface. Colloids Surf B Biointerfaces. 2014;123:143–9.
Article
CAS
PubMed
Google Scholar
David L, et al. Host lifestyle affects human microbiota on daily timescales. Genome Biol. 2014;15:R89.
Article
PubMed
PubMed Central
CAS
Google Scholar
Butel M, et al. Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J Pediatr Gastroenterol Nutr. 2007;44:577–82.
Article
PubMed
Google Scholar
Salminen S, Gibson GR, McCartney AL, Isolauri E. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut. 2004;5:1388–9.
Article
Google Scholar
Azad MB, et al. Gut microbiota of healthy canadian infants: profiles by mode of delivery and infant diet at 4 months. CMAJ. 2013;185:385–94.
Article
PubMed
PubMed Central
Google Scholar
Cho I, et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nat. 2012;488:621–6.
Article
CAS
Google Scholar
Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci U S A. 2011;108:4554–61.
Article
CAS
PubMed
Google Scholar
Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biology. 2008;6:2383–400.
Article
CAS
Google Scholar
Jakobsson HE, et al. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One. 2010;5:e9836.
Article
PubMed
PubMed Central
CAS
Google Scholar
Turnbaugh PJ, et al. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1:6ra14.
Article
PubMed
PubMed Central
CAS
Google Scholar
Bai J, Hu Y, Bruner DW. Composition of gut microbiota and its association with body mass index and lifestyle factors in a cohort of 7–18 years old children from the american gut project. Pediatric Obesity. 2019;14:e12480.
Article
CAS
PubMed
Google Scholar
Vasapolli R, et al. Analysis of transcriptionally active bacteria throughout the gastrointestinal tract of healthy individuals. Gastroenterology. 2019;157:1081–92.
Article
CAS
PubMed
Google Scholar
Panek M, et al. Methodology challenges in studying human gut microbiota - effects of collection, storage, DNA extraction and next generation sequencing technologies. Sci Rep. 2018;8:5143–13.
Article
PubMed
PubMed Central
CAS
Google Scholar
Costea PI, et al. Towards standards for human fecal sample processing in metagenomic studies. Nature Biotechnology. 2017;35:1069–76.
Article
CAS
PubMed
Google Scholar
Qin J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nat. 2016;464:59–65.
Article
CAS
Google Scholar
Reyes A, et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature. 2010;466:334–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cani PD. Current insights and challenges when studying the human gut microbiome. Gut Microbiota for Health. 2018.https://www.gutmicrobiotaforhealth.com/en/current-insights-and-challenges-when-studying-the-human-gut-microbiome/.
Morton J, et al. Balance trees reveal microbial niche differentiation. Msystems. 2017;2:e00162–16.
CAS
PubMed
PubMed Central
Google Scholar
Vandeputte D, et al. Quantitative microbiome profiling links gut community variation to microbial load. Nat. 2017;551:507.
Article
CAS
Google Scholar
Badal V, et al. Challenges in the construction of knowledge bases for human microbiome-disease associations. Microbiome. 2019;7:129–15.
Article
PubMed
PubMed Central
Google Scholar